Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 02-2023 | 11-2022 | 09-2022 | 08-2022 | 05-2022 | |
| Sales | 12,685 | 6,783 | 0 | 10,791 | 11,432 |
| Gross Profit | 12,685 | 6,783 | N/A | 10,791 | 11,432 |
| Operating Expenses | 55,637 | 55,473 | 0 | 57,509 | 57,147 |
| Operating Income | -42,952 | -48,690 | N/A | -46,718 | -45,715 |
| Other Income | 2,219 | 1,973 | 0 | 1,009 | 314 |
| Pre-tax Income | -40,733 | -46,717 | 0 | -45,709 | -45,401 |
| Net Income Continuous | -40,733 | -46,717 | N/A | -45,709 | -45,401 |
| Net Income | $-40,733 | $-46,717 | $N/A | $-45,709 | $-45,401 |
| EPS Basic Total Ops | -0.75 | -0.85 | N/A | -0.90 | -1.01 |
| EPS Basic Continuous Ops | -0.75 | -0.85 | N/A | -0.90 | -1.01 |
| EPS Diluted Total Ops | -0.75 | -0.85 | N/A | -0.90 | -1.01 |
| EPS Diluted Continuous Ops | -0.75 | -0.85 | N/A | -0.90 | -1.01 |
| EBITDA(a) | $-40,590 | $-46,303 | $N/A | $-43,749 | $-42,632 |